Fact CheckerSign in

NCT07333989Recruiting

Effect of Biofeedback Activation on Balance in Osteoporotic Elderly

Effect of Biofeedback Activation on Balance in Osteoporotic Elderly Patients

Source: ClinicalTrials.gov · Last updated 20 Mar 2026

Brief summary (registry, in English)

This study aimed to investigate the effect of gluteus medius activation using electromyography (EMG) biofeedback combined with balance training on balance, physical performance, gluteus medius muscle activity, and quality of life in osteoporotic elderly patients.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
30 Dec 2025
Start date
Jan 2026
Primary completion date
Apr 2026
Lead sponsor
Mohamed Said Alsafy Alhamrawy
Diseases
Osteoporosis
NCT number
NCT07333989

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From Jan 2026 to the primary completion date, Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • The potential patients were excluded if they have one of the following criteria:
    • Patients with endocrine disorders likely to be related to metabolic bone disease, such as premature ovarian failure, hypogonadism, untreated hyperthyroidism, hyperparathyroidism, adrenal insufficiency or Cushing's syndrome.
    • Patients with active contagious skin conditions.
    • Patients with implant devices such as pacemaker or electrical prosthesis.
    • Any cardiopulmonary disorders.
    • Any neuromuscular disorders.
    • Any acute viral infection.
    • Patients with ascites or end stage liver or kidney failure.
    • Leg discrepancy.

Who the study is looking for

  • All patients included in this study met the following criteria:
    • Sixty patients of both sexes were diagnosed with osteoporosis confirmed by bone density test through Dual-energy X-ray absorptiometry (DEXA) scan (A T-score equal to or less than - 2.5) (Sheu and Diamond, 2016).
    • Their age ranged between 65 - 75 years.
    • Their BMI ranged between 25 - 29.9 kg/m2.
    • They had good mentality and cognitive function.

Age in the registry: 65 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
General Hospital Abouhms
Coordinator of this site? Confirm its status
Abū ḨummuşEgyptRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.